Angcot, Randy T.
HRN: 23-48-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/12/2024
02/19/2024
IV
500mg
Atb6am Then Q8
Hemorrhoids Grade 3
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes